Differential binding of peptides substituted at putative C-terminal anchor residues to HLA-DQ8 and DQ9 differing only at β57

Human Immunology

Volumn 52, Issue 1, 1997, Pages 47-53

  Oiso, Masatake ^a,b   Nishi, Tohru ^b   Ishikawa, Takeru ^b   Nishimura, Yasuharu ^a   Matsushita, Sho ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; AMINO TERMINAL SEQUENCE; ANTIGEN BINDING; ARTICLE; AUTOIMMUNITY; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; CONSERVED SEQUENCE; HLA-DQ ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; THREONINE;

EID: 0031018166     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(96)00253-4     Document Type: Article

References (31)

1. 1. Harrison LC: Islet cell autoantigens in insulin-dependent diabetes: Pandora's Box revisited. Immunol Today 13: 348, 1992.
2. 2. Tisch R, Yang X-D, Singer SM, Liblau RS, Fugger L, McDevitt HO: Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366:72, 1993.
3. 3. Atkinson MA, Kaufman DL, Campbell L, Gibbs KA, Shah SC, Bu D-F, Erlander MG, Tobin AJ, Maclaren NK: Response of peripheral blood mononuclear cells to glutamine decarboxylase in insulin-dependent diabetes. Lancet 339:458, 1992.
4. 4. Oldstone MB: Molecular mimicry and autoimmune disease. Cell 50:819, 1987.
5. 5. King ML, Shaikh A, Bidwell D, Voller A, Banatvala JE: Coxsackie-B-virus-specific IgM responses in children with insulin-independent (juvenile-onset; type I) diabetes mellitus. Lancet 339:1397, 1983.
6. 6. Schernthaner G, Banatvala JE, Scherbaum W, Bryant J, Borkenstein M, Schober E, Mayr WR: Coxsackie-B-virus specific IgM responses, complement-fixing islet-cell antibodies, HLA-DR antigens, and C-peptide secretion in insulin-dependent diabetes mellitus. Lancet 456:630, 1985.
7. 7. Hou J, Said C, Franchi D, Dockstader P, Chatterjee NK: Antibodies to glutamic acid decarboxylase and P2-C peptides in sera from coxsackie virus B4-infected mice and IDDM patients. Diabetes 43:1260, 1994.
8. 8. Tian J, Lehmman PV, Kaufman DL: T cell cross-reactivity between coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J Exp Med 180:1979, 1994.
9. 9. Todd JA, Bell JI, McDevitt HO: HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature Lond. 329:599, 1987.
10. 10. Dorman JS, LaPorte RE, Stone RA, Trucco M: World wide differences in the incidence of type 1 diabetes are associated with amino acid variation at position 57 of the HLA-DQ beta chain, Proc Natl Sci USA 87:7370, 1990.
11. 11. Røinningen KS, Spurkland A, Tait BD, Drummond B, Lopez-Larrea C, Baranda FS, Menendez-Diaz MJ, Caillat-Zucman S, Beaurain G, Garchon H-J, Reijonen H, Knip M, Boehm BO, Rosak C, Löliger C, Kühnl P, Ottenhoff T, Contu L, Carcassi C, Savi M, Zanelli P, Neri TM, Hamaguchi K, Kimura A, Dong RP, Chikuba N, Nagataki S, Gorodezxy C, Debaz H, Rubles C, Coimbra HB, Martinho A, Ruas MA, Sacha JA, Garcia-Pachedo M, Biro A, Nikaein A, Dombrausky L, Gonwa T, Zmijewski C, Monos D, Kamoun M, Layrisse Z, Magli MC, Balducci P, Thorsby E: HLA class II associations in insulin-dependent diabetes mellitus among blacks, Caucasoids, and Japanese. In Tsuji K, Aizawa M, Sasazuki T (eds): HLA 1991, vol 1. Oxford, Oxford Science, 1992, p 713.
12. 12. Marcelo AF-V, Falco M, Raimond X, Stastny P: DQA1*03 subtypes have different associations with DRB1 and DQB1 alleles. Hum Immunol 39:290, 1994.
13. 13. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC: Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215, 1994.
14. 14. Matsushita S, Takahashi K, Motoki M, Komoriya K, Ikagawa S, Nishimura Y: Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome. J Exp Med 180:873, 1994.
15. 15. Khalil I, Deschamps I, Lepage V, Al-Daccak R, Degos L, Hors J: Dose effect of cis- and trans-encoded HLA-DQαβ heterodimers in IDDM susceptibility. Diabetes 41:378, 1992.
16. 16. Scott JK, Smith GP: Searching for peptide ligands with an epitope library. Science Wash DC 249:386, 1990.
17. 17. Pathan A, Green T, Brown J, Navarrette C: Characterization of a polymorphic HLA-DR monoclonal produced by using HLA class II tranfectant L cells. In K Tsuji, M. Aizawa, T. Sasazuki (eds): HLA 1991, vol 1. Oxford, Oxford Science, 1992, p 933.
18. 18. Fujisao S, Matsushita S, Nishi T, Nishimura Y: Identification of HLA-DR9 (DRB1*0901)-binding peptide motifs using a phage fUSE5 random peptide library. Hum Immunol 45:131, 1996.
19. 19. Ikagawa S, Matsushita S, Chen Y-Z, Ishikawa T, Nishimura Y: Single amino acid substitutions on a Japanese cedar pollen allergen (Cry j I)-derived peptide induced alterations in human T cell repsonses and T cell receptor antagonism. J Allergy Clin Immunol 97:53, 1996.
20. 20. Bodmer JG, Marsh SGE, Aibert ED, Bodmer WF, Dupont B, Erlich HA, March B, Mayr WR, Parham P, Sasazuki T: Nomenclature for factors of the HLA system. Hum Immunol 41:1, 1994.
21. 21. Kasahara M, Takenouchi T, Ogasawara K, Ikeda H, Okuyama T, Ishikawa N, Moriuchi J, Wakisaka A, Kikuchi Y, Aizawa M, Kaneko T, Kashiwagi N, Nishimura Y, Sasazuki T: Serologic dissection of HLA-D specificities by the use of monoclonal antibodies. Immunogenetics 17: 485, 1983.
22. 22. Matsushita S, Nishi T, Oiso M, Yamaoka K, Yone K, Kanai T, Nishimura Y: HLA-DQ-binding peptides motifs. I. Comparative binding analysis of type II collagen-derived peptides to DR and DQ molecules of rheumatoid arthritis-susceptible and non-susceptible haplotypes. Int Immunol 8:757, 1996.
23. 23. Kwok WW, Nepom GT, Raymond FC: HLA-DQ polymorphisms are highly selective for peptide binding interactions. J Immunol 155:2468, 1995.
24. 24. Roman MC, Lane WS, Robinson RA, Trucco M, Strominger JL, Gorga JC: Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8. Int Immunol 6:1639, 1994.
25. 25. Sidney J, Oseroff C, del Guercio MF, Southwood S, Krieger JI, Ishioka GY, Sakaguchi K, Appella E, Sette A: Definition of a DQ3.1-specific binding motif. J Immunol 152:4516, 1994.
26. 26. Hammer J, Bono E, Gallazzi F, Belunis C, Nagy Z, Sinigaglia F: Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning. J Exp Med 180:2353, 1994.
27. 27. Maeda H, Hirata R, Chandanayingyong D, Loon J, Lepage V, Bignon JD, Hammond MG: HLA-DQ3, -DQ4, -DQ7, -DQ8, -DQ9. In Tsuji K, Aizawa M, Sasazuki T (eds): HLA 1991, vol 1. Oxford, Oxford Science, 1992, p 383.
28. 28. Sherman LA, Chattopadhyay S, Bibbs JA, Dick RF, Bluestone JA: Alloantibodies can discriminate class I major histocompatibility complex molecules associated with various endogenous peptides. Proc Natl Sci USA 90:6949, 1993.
29. 29. Verreck FA, van de Paul A, Termijtelen A, Amons R, Drijfhount JW, Koning F: Identification of an HLA-DQ2 peptide binding motif and HLA-DPw3-bound self-peptide by pool sequencing. Eur J Immunol 24:375, 1994.
30. 30. Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK: Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest 94:2125, 1994.
31. 31. Wogensen L, Lee MS, Sarvetnick N: Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice. J Exp Med 179:1379, 1994.